CHARLES MERCER: Open Payments
NPI 1760724124 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 12 payments from 8 companies in 2025. Trend: 2023 $766 · 2024 $376 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $129 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Ardelyx, Inc. | 1 | $124 |
| Paratek Pharmaceuticals, Inc. | 5 | $96 |
| Reapplix Inc. | 1 | $73 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Reprise Biomedical, Inc. | 1 | $20 |
| Smith+Nephew, Inc. | 1 | $16 |
Products named: Veozah, Auvelity, IBSRELA, NUZYRA, 3C Patch Kit - Box, FUROSCIX, Miro3D, COLLAGENASE SANTYL.
Industry payments across LA — which companies pay providers there.
